Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3074957 | 0.87 | ALOX5 (0.37) | — | |
| SCHEMBL3131316 | 0.81 | DRD2 (0.34) | LMNA | |
| SCHEMBL29244396 | 0.75 | NISCH (0.33) | — | |
| SCHEMBL25430258 | 0.73 | ALDH1A1 (0.35) | ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL28143327 | 0.73 | NPC1 (0.36) | ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL2446923 | 0.72 | KDM4E (0.43) | ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL30618039 | 0.72 | RPS6KB2 (0.34) | ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL29664451 | 0.71 | NISCH (0.32) | — | |
| SCHEMBL9368915 | 0.71 | NISCH (0.31) | — | |
| SCHEMBL31540166 | 0.70 | NISCH (0.44) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240417263-A1 | METHOD OF FORMING GRAPHENE FILMS | UNIVERSITY OF MASSACHUSETTS | 2024-12-19 | — | — | US | claimed |
| EP-4419481-A2 | METHOD OF FORMING GRAPHENE FILMS | University Of Massachusetts (US) | 2024-08-28 | — | — | EP | claimed |
| WO-2023132979-A2 | METHOD OF FORMING GRAPHENE FILMS | UNIVERSITY OF MASSACHUSETTS (US) | 2023-07-13 | — | — | WO | claimed |
| US-20240417263-A1 | METHOD OF FORMING GRAPHENE FILMS | UNIVERSITY OF MASSACHUSETTS | 2024-12-19 | — | — | US | disclosed |
| EP-4419481-A2 | METHOD OF FORMING GRAPHENE FILMS | University Of Massachusetts (US) | 2024-08-28 | — | — | EP | disclosed |
| CN-117658939-A | Method for synthesizing non-natural beta-amino acid compound by rhodium catalysis | 河南大学 | 2024-03-08 | — | — | CN | disclosed |
| US-11834424-B2 | Compounds useful as chaperone-mediated autophagy modulators | ALBERT EINSTEIN COLLEGE OF MEDICINE (US) | 2023-12-05 | — | — | US | disclosed |
| EP-4212516-A1 | 2-PHENYL-6-HALO-QUINOXALINE DERIVATIVES AS CHAPERONE-MEDIATED AUTOPHAGY (CMA) MODULATORS FOR THE TREATMENT OF PARKINGSON'S DISEASE | Albert Einstein College of Medicine (US) | 2023-07-19 | — | — | EP | disclosed |
| WO-2023132979-A2 | METHOD OF FORMING GRAPHENE FILMS | UNIVERSITY OF MASSACHUSETTS (US) | 2023-07-13 | — | — | WO | disclosed |
| US-20210317095-A1 | COMPOUNDS USEFUL AS CHAPERONE-MEDIATED AUTOPHAGY MODULATORS | ALBERT EINSTEIN COLLEGE OF MEDICINE | 2021-10-14 | — | — | US | disclosed |
| EP-3844155-A1 | COMPOUNDS USEFUL AS CHAPERONE-MEDIATED AUTOPHAGY MODULATORS | Albert Einstein College of Medicine (US) | 2021-07-07 | — | — | EP | disclosed |
| CN-112714761-A | Compounds useful as chaperone mediated modulators of autophagy | 阿尔伯爱因斯坦医学院 | 2021-04-27 | — | — | CN | disclosed |
| WO-2020046335-A1 | COMPOUNDS USEFUL AS CHAPERONE-MEDIATED AUTOPHAGY MODULATORS | ALBERT EINSTEIN COLLEGE OF MEDICINE, INC. (US) | 2020-03-05 | — | — | WO | disclosed |
| CN-107083027-A | Oxazines resin combination and its manufacture method, prepreg, plywood and hardening thing | 新日铁住金化学株式会社 | 2017-08-22 | — | — | CN | disclosed |
| EP-2571937-A2 | POLYMER COMPOSITIONS CONTAINING OXAZINE-BASED ALKOXYSILANES | Dow Corning Corporation (US) | 2013-03-27 | — | — | EP | disclosed |
| US-20130065992-A1 | Polymer Compositions Containing Oxazine-Based Alkoxysilanes | DOW CORNING CORPORATION (US) | 2013-03-14 | — | — | US | disclosed |
| WO-2011144575-A2 | POLYMER COMPOSITIONS CONTAINING OXAZINE-BASED ALKOXYSILANES | DOW CORNING CORPORATION (US) | 2011-11-24 | — | — | WO | disclosed |
| EP-2217651-A2 | CURABLE COMPOSITIONS CONTAINING ISOCYANATE-BASED TOUGHENERS | Henkel AG & Co. KGaA (DE) | 2010-08-18 | — | — | EP | disclosed |
| WO-2009075743-A2 | CURABLE COMPOSITIONS CONTAINING ISOCYANATE-BASED TOUGHENERS | HENKEL AG & CO. KGAA (DE) | 2009-06-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11834424-B2 | Compounds useful as chaperone-mediated autophagy modulators | SQSTM1, HSPA5, ATG7 | ALDH1A1 2631/4885LMNA 3765/4885SMN1; SMN2 2417/4885 |
| US-20210317095-A1 | COMPOUNDS USEFUL AS CHAPERONE-MEDIATED AUTOPHAGY MODULATORS | SQSTM1, HSPA5, ATG7 | ALDH1A1 2631/4885LMNA 3765/4885SMN1; SMN2 2417/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.